Fellowship · Charlotte, NC
Sponsored by Carolinas Medical Center
Exagamglogene Autotemcel for Severe Sickle Cell Disease.
The New England journal of medicine · 2024 · 351 citations · Michael Eckrich
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Neuro-oncology · 2023 · 466 citations · Ashley Sumrall
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
Neuro-oncology · 2022 · 470 citations · Ashley Sumrall
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 233 citations · Jimmy Hwang
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Cancer discovery · 2023 · 146 citations · Ashley Sumrall
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 95 citations ·
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025 · 51 citations · Daniel Carrizosa
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2022 · 161 citations · Jimmy Hwang